Cargando…

Butyrate Stimulates Histone H3 Acetylation, 8-Isoprostane Production, RANKL Expression, and Regulated Osteoprotegerin Expression/Secretion in MG-63 Osteoblastic Cells

Butyric acid as a histone deacetylase (HDAC) inhibitor is produced by a number of periodontal and root canal microorganisms (such as Porphyromonas, Fusobacterium, etc.). Butyric acid may affect the biological activities of periodontal/periapical cells such as osteoblasts, periodontal ligament cells,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chang, Mei-Chi, Chen, Yunn-Jy, Lian, Yun-Chia, Chang, Bei-En, Huang, Chih-Chia, Huang, Wei-Ling, Pan, Yu-Hwa, Jeng, Jiiang-Huei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6321057/ https://www.ncbi.nlm.nih.gov/pubmed/30562925 http://dx.doi.org/10.3390/ijms19124071

Ejemplares similares

Effect of Butyrate on Collagen Expression, Cell Viability, Cell Cycle Progression and Related Proteins Expression of MG-63 Osteoblastic Cells
por: Chang, Mei-Chi, et al.
Publicado: (2016)

Effects of treatment with local anesthetics on RANKL expression in MG63 and PDL cells
por: Huang, Tsui-Hsein, et al.
Publicado: (2021)

Transglutaminase-2 Is Involved in Expression of Osteoprotegerin in MG-63 Osteosarcoma Cells
por: Lee, Hye Ja, et al.
Publicado: (2013)

Biology of RANK, RANKL, and osteoprotegerin
por: Boyce, Brendan F, et al.
Publicado: (2007)

Expression of osteoprotegerin and its ligands, RANKL and TRAIL, in rheumatoid arthritis
por: Remuzgo-Martínez, Sara, et al.
Publicado: (2016)

Estrogen stimulates osteoprotegerin expression via the suppression of miR-145 expression in MG-63 cells
por: Jia, Jun, et al.
Publicado: (2017)

Serum RANKL, osteoprotegerin (OPG), and RANKL/OPG ratio in nephrotic children
por: Wasilewska, Anna, et al.
Publicado: (2010)

The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
por: Starlinger, Julia, et al.
Publicado: (2019)

RANK, RANKL and osteoprotegerin in bone biology and disease
por: Wright, H. L., et al.
Publicado: (2009)

Association of salivary RANKL and osteoprotegerin levels with periodontal health
por: Ochanji, A. A., et al.
Publicado: (2017)

The Simultaneous Inhibitory Effect of Niclosamide on RANKL-Induced Osteoclast Formation and Osteoblast Differentiation
por: Liu, Fei-Lan, et al.
Publicado: (2017)

Effects of alpha-calcitonin gene-related peptide on osteoprotegerin and receptor activator of nuclear factor-κB ligand expression in MG-63 osteoblast-like cells exposed to polyethylene particles
por: Xu, Jie, et al.
Publicado: (2010)

(99)Tc-MDP-induced human osteoblast proliferation, differentiation and expression of osteoprotegerin
por: Chen, Jie, et al.
Publicado: (2017)

Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling
por: Chang, Mei-Chi, et al.
Publicado: (2016)

LAMP-2 Is Involved in Surface Expression of RANKL of Osteoblasts In Vitro
por: Jansen, Ineke D.C., et al.
Publicado: (2020)

Effects of pamidronate disodium on the loss of osteoarthritic subchondral bone and the expression of cartilaginous and subchondral osteoprotegerin and RANKL in rabbits
por: Lv, You, et al.
Publicado: (2014)

NOTCH1 Mutations in Aortic Stenosis: Association with Osteoprotegerin/RANK/RANKL
por: Irtyuga, Olga, et al.
Publicado: (2017)

The association of osteoprotegerin and RANKL with osteoporosis: a systematic review with meta-analysis
por: Chi, Guanghao, et al.
Publicado: (2023)

Local Production of Osteoprotegerin by Osteoblasts Suppresses Bone Resorption
por: Cawley, Keisha M., et al.
Publicado: (2020)

Osteoprotegerin, s-RANKL, and selected interleukins in the pathology of bone metabolism in patients with Crohn's disease
por: Krela-Kaźmierczak, Iwona, et al.
Publicado: (2015)

Expression and localization of TASK-1, -2 and -3 channels in MG63 human osteoblast-like cells
por: LI, XIANTAO, et al.
Publicado: (2013)

Effects of fluoridation of porcine hydroxyapatite on osteoblastic activity of human MG63 cells
por: Li, Zhipeng, et al.
Publicado: (2015)

Role of RANKL–RANK/osteoprotegerin molecular complex in bone remodeling and its immunopathologic implications
por: Kohli, Sarvraj Singh, et al.
Publicado: (2011)

Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis
por: Behfarnia, Parichehr, et al.
Publicado: (2016)

Internalized Gold Nanoparticles Do Not Affect the Osteogenesis and Apoptosis of MG63 Osteoblast-Like Cells: A Quantitative, In Vitro Study
por: Tsai, Shiao-Wen, et al.
Publicado: (2013)

RANKL/RANK is required for cytokine-induced beta cell death; osteoprotegerin, a RANKL inhibitor, reverses rodent type 1 diabetes
por: Kondegowda, Nagesha Guthalu, et al.
Publicado: (2023)

Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL
por: Schieferdecker, Aneta, et al.
Publicado: (2014)

Erratum: Serum, saliva, and GCF concentration of RANKL and osteoprotegerin in smokers versus nonsmokers with chronic periodontitis
Publicado: (2016)

Osteoprotegerin and RANKL-RANK-OPG-TRAIL signalling axis in heart failure and other cardiovascular diseases
por: Dutka, Mieczysław, et al.
Publicado: (2021)

Tramadol enhances PGF(2α)-stimulated osteoprotegerin synthesis in osteoblasts
por: Kim, Woo, et al.
Publicado: (2020)

Expression and Regulation of Osteoprotegerin in Adipose Tissue
por: An, Juan-Ji, et al.
Publicado: (2007)

Serum from patients with ankylosing spondylitis can increase PPARD, fra-1, MMP7, OPG and RANKL expression in MG63 cells
por: Hu, Zaiying, et al.
Publicado: (2015)

Avicularin Reduces the Expression of Mediators of Inflammation and Oxidative Stress in Bradykinin-Treated MG-63 Human Osteoblastic Osteosarcoma Cells
por: Zhang, Zhentao, et al.
Publicado: (2020)

Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor-κB ligand in osteoblasts in vivo and in vitro
por: LI, JINGWU, et al.
Publicado: (2016)

Osteoblast CFTR Inactivation Reduces Differentiation and Osteoprotegerin Expression in a Mouse Model of Cystic Fibrosis-Related Bone Disease
por: Stalvey, Michael S., et al.
Publicado: (2013)

NF-κB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor
por: Kubota, Tetsuo, et al.
Publicado: (2007)

Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013)

Effect of Hydroxyapatite Formation on Titanium Surface with Bone Morphogenetic Protein-2 Loading through Electrochemical Deposition on MG-63 Cells
por: Huang, Huei Yu, et al.
Publicado: (2018)

Platelet function and Isoprostane biology. Should Isoprostanes be the newest member of the Orphan-ligand family?
por: Ting, Harold J, et al.
Publicado: (2010)

Angiogenesis-Related Cytokines, RANKL, and Osteoprotegerin in Multiple Myeloma Patients in relation to Clinical Features and Response to Treatment
por: Sfiridaki, K., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_brt5m5he0bupt0o7u304i4ckq8